Search

everythinglearnresearchcommunity

for

Search:↓

Deucravacitinib did not significantly improve hair regrowth in alopecia areata patients.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Treating primary cicatricial alopecia is difficult and requires evidence-based methods.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

Keratin mutations cause skin diseases and could lead to new treatments.

Geranyl acetate can protect skin cells from damage and inflammation caused by para-phenylenediamine.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

Near-infrared probes can safely and effectively image cysteine protease activity for disease diagnosis.

TRIV-509 quickly improves skin barrier and cell health in atopic dermatitis.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Biochanin A from soy is a promising and safe candidate for treating hair loss.

Microneedles help treat hair loss by improving hair surroundings and promoting growth.

Upadacitinib may effectively treat alopecia areata without side effects.

34% of patients on hepatitis C treatment had reversible skin issues.

Blocking CYP17A1 enzyme may help improve certain brain function issues related to dopamine.

Cyclosporin A vesicles effectively regrow hair and reduce inflammation in alopecia areata.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

Imatinib can repigment grey hair, while SU11428 can cause temporary hair depigmentation.

Topical cetirizine improves hair density and thickness in androgenetic alopecia, but more research is needed.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

Inhibiting ACE2 improves skin regeneration during tissue expansion.

Using three different drugs together may better treat eye diseases like glaucoma and macular degeneration.

Some blood pressure medications are linked to a higher risk of skin cancer.

Doctors should actively prevent and treat skin side effects in cancer patients to keep them on the best medication and reduce discomfort.

Various dermatologic treatments were effective for skin conditions like acne, rosacea, hair loss, and psoriasis from December 1986 to December 1987.

Semecarpus anacardium leaf extracts may offer safe, effective cancer treatment alternatives.

JAK inhibitors, like ruxolitinib, may effectively treat frontal fibrosing alopecia.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.